Her Majesty Queen Máxima of the Netherlands attended the Third Congress of European Academy of Neurology (EAN) in Amsterdam on Monday. It ran from 24 June through today and had previously been hosted in Copenhagen, Istanbul and Berlin. It will be in Lisbon, Portugal, in 2018.
The event took place in the RAI in the city with various neurological topics being discussed. Leading experts in different neurological fields from all over the world were on hand to talk about their research; thousands attended the 2017 event which consisted of 80 different sessions.
EAN President Prof Guenther Deuschl said about the Queen’s visit, “The EAN is very honoured by Queen Máxima’s visit and is delighted with the interest she showed in the topics we are discussing at the congress.
“In fact, there is hardly another discipline that is developing as rapidly as neurology. And this fast pace is urgently required given the growing disease burden. Data from the European Brain Council indicates that a total of 220.7 million people in Europe suffer from at least one neurological disease – that is more than the populations of Germany, France and Great Britain combined.
“Sufficient funding for brain research activities and adequate care for neurological patients must, therefore, be given high priority throughout Europe.”
The Queen of the Netherlands heard experts speak on diseases such as strokes, epilepsy, movement disorders, multiple sclerosis, dementia, neuromuscular disorders, and other rare neurological diseases; they also presented the trends and highlights in modern neurological research and therapies.
Specifically, she attended the lecture on “Outcome measures in neurology.” The EAN said in a press release, “This important field deals, inter alia, with objective and patient-reported indicators for the impact of neurological conditions on the patients’ well-being. It also helps to decide on the effectiveness of treatments.”
Her Majesty met some of the presenters and leading experts as well as those who are suffering from a neurological disease.
Over 6,000 people were in attendance alongside Queen Máxima at the EAN Congress this year. The overarching theme this year focuses on outcome measures in neurology with the central question on the measurement of the impact of the diseases and treatments.
Various companies had exhibits on hand for the duration of the EAN Congress. These businesses included the American Academy of Neurology, Britannia Pharmaceuticals, Federation of European Neuroscience Societies, International Parkinson and Movement Disorder Society and the World Federation of Neurology.
This is not the first time Her Majesty has shown support for research and awareness of neurological related diseases. Back in 2012, then-Princess Máxima took part in the Amsterdam City Swim which was organised to fund research in the battle against the amyotrophic lateral sclerosis (ALS).